Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 12/20 | 0.80 |
| ▸ | F10 | P00742 | 11/20 | 0.64 |
| ▸ | PLG | P00747 | 7/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7979435 | 0.89 | F2 (1.00) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7984501 | 0.88 | F2 (0.98) | F2F10PLGPRSS1PRSS2 | |
| SCHEMBL7426925 | 0.82 | F2 (0.72) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7981512 | 0.80 | F2 (0.79) | F2F10PLGPRSS1PRSS2 | |
| SCHEMBL7968288 | 0.78 | F2 (1.00) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7424078 | 0.78 | F2 (0.75) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7981375 | 0.77 | F2 (0.98) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7982145 | 0.77 | F2 (0.98) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7480202 | 0.77 | F2 (0.87) | F2F10PLGPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL7979947 | 0.75 | F2 (0.74) | F2F10PLGPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6200976-B1 | FOR TREATING THROMBOSIS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-03-13 | — | — | US | disclosed |